UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 11 | November 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 11
November-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2511469


Registration ID:
571855

Page Number

e556-e565

Share This Article


Jetir RMS

Title

DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF NOVEL QUINAZOLINE DRUG AS POTENTIAL ANTICANCER AGENTS.

Abstract

Quinazoline-based heterocycles represent one of the most versatile scaffolds in modern anticancer drug discovery due to their ability to interact with multiple molecular targets, particularly tyrosine kinases implicated in tumor progression. In this study, a series of novel quinazoline derivatives were rationally designed through structure-based optimization aimed at enhancing interaction with key oncogenic kinases such as EGFR and VEGFR. Computational tools, including molecular docking and ADME prediction, were employed to identify structural features crucial for target affinity and drug-likeness. The designed compounds were conceptually synthesized through established quinazoline-building strategies and characterized using appropriate spectroscopic techniques. Biological evaluation against a panel of human cancer cell lines demonstrated that several derivatives exhibited significant cytotoxic activity with favorable selectivity profiles. Mechanistic assays suggested that these compounds may induce apoptosis and disrupt critical signaling pathways associated with cell proliferation and survival. Overall, the results highlight the quinazoline scaffold as a promising platform for developing potent anticancer agents and provide valuable insights for future optimization and lead development.

Key Words

Anticancer , Cell line, immunotherapy, Oncolytic viruses, CAR-T cell therapy

Cite This Article

"DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF NOVEL QUINAZOLINE DRUG AS POTENTIAL ANTICANCER AGENTS.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 11, page no.e556-e565, November-2025, Available :http://www.jetir.org/papers/JETIR2511469.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF NOVEL QUINAZOLINE DRUG AS POTENTIAL ANTICANCER AGENTS.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 11, page no. ppe556-e565, November-2025, Available at : http://www.jetir.org/papers/JETIR2511469.pdf

Publication Details

Published Paper ID: JETIR2511469
Registration ID: 571855
Published In: Volume 12 | Issue 11 | Year November-2025
DOI (Digital Object Identifier):
Page No: e556-e565
Country: Buldhana, Maharastra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00026

Print This Page

Current Call For Paper

Jetir RMS